114 related articles for article (PubMed ID: 2611955)
1. [Immunologic changes in active pulmonary tuberculosis treated with a fuzheng guben pill].
Li CY
Zhong Xi Yi Jie He Za Zhi; 1989 Nov; 9(11):663-5, 645. PubMed ID: 2611955
[TBL] [Abstract][Full Text] [Related]
2. [Agranulocytosis due to anti-tuberculosis drugs including isoniazid (INH) and rifampicin (RFP)--a report of four cases and review of the literature].
Shishido Y; Nagayama N; Masuda K; Baba M; Tamura A; Nagai H; Akagawa S; Kawabe Y; Machida K; Kurashima A; Komatsu H; Yotsumoto H
Kekkaku; 2003 Nov; 78(11):683-9. PubMed ID: 14672045
[TBL] [Abstract][Full Text] [Related]
3. [A case of pulmonary tuberculosis complicated with drug toxicosis--value of shosaikoto and hochuekito as anti-allergic agents].
Onodera H; Kasamatsu Y; Tsujimoto S; Takemura S; Okamoto M; Seto N; Nakanishi S; Nakahara R; Ichio N; Doi T
Kekkaku; 1993 Jan; 68(1):23-9. PubMed ID: 8437420
[TBL] [Abstract][Full Text] [Related]
4. [Body reactivity in pulmonary tuberculosis patients who are alcoholics].
Samtsov VS; Volosevich GV
Probl Tuberk; 1981 May; (5):26-30. PubMed ID: 6973151
[No Abstract] [Full Text] [Related]
5. Effects of chemotherapy on the immunological characteristics of patients with primary destructive pulmonary tuberculosis.
Khomenko AG; Averbach MM; Litvinov VI; Gergert VJ; Chukanov VI
Bull World Health Organ; 1984; 62(5):763-71. PubMed ID: 6391716
[TBL] [Abstract][Full Text] [Related]
6. [State of the T- and B-systems of immunity in pulmonary tuberculosis].
Volosevich GV; Solov'eva AS
Probl Tuberk; 1977 Jul; (7):25-7. PubMed ID: 302448
[No Abstract] [Full Text] [Related]
7. [The immunological criteria in the expediency of prescribing T-activin to patients with primary pulmonary tuberculosis].
Sakhelashvili-Haladzhun MI
Lik Sprava; 1994; (9-12):103-5. PubMed ID: 7604543
[TBL] [Abstract][Full Text] [Related]
8. [Immunological correction in progressive pulmonary tuberculosis].
Maslennikov AA; Kamenev VF; Kolomiets VM
Probl Tuberk Bolezn Legk; 2007; (9):30-3. PubMed ID: 18038603
[TBL] [Abstract][Full Text] [Related]
9. [Immunological studies in the treatment of tuberculosis with flureniside].
Sibirnaia RI
Probl Tuberk; 1997; (5):27-8. PubMed ID: 9454246
[TBL] [Abstract][Full Text] [Related]
10. [Immune system in children with pulmonary tuberculosis].
Elufimova VF; Mitinskaia LA; Romanova RIu; Abramova ZP
Probl Tuberk; 1995; (1):13-5. PubMed ID: 7761370
[TBL] [Abstract][Full Text] [Related]
11. [Evaluation of initial combined chemotherapy with SM, INH and EB for pulmonary tuberculosis. 2. Comparison of SM, EB and INH regimen with that of SM, PAS and INH for experimental tuberculosis of mice].
Makiyama H
Kekkaku; 1971 Aug; 46(8):303-8. PubMed ID: 5570128
[No Abstract] [Full Text] [Related]
12. [Clinical evaluation of Rifampicin in pulmonary tuberculosis. 2. A controlled trial on the clinical effects of chemotherapy with Rifampicin-INH-PAS and SM-INH-PAS for treatment of original cases of pulmonary tuberculosis].
Donomae I; Fujita S; Gomi J; Hibino S; Horai Z
Kekkaku; 1970 Aug; 45(8):257-62. PubMed ID: 4918166
[No Abstract] [Full Text] [Related]
13. [Effect of phytohemagglutinin on immunological reactions in experimental tuberculosis].
Chernushenko EF; Chumak AA; Gomoliako IV
Probl Tuberk; 1981 Feb; (2):50-3. PubMed ID: 6972528
[No Abstract] [Full Text] [Related]
14. [Evaluation of the streptomycin twice weekly with INH and RFP for initial therapy of pulmonary tuberculosis].
Toyota E; Suzuki T; Tagawa K; Takahara M; Ito M; Arai T; Kabe J; Baba H
Kekkaku; 1994 Sep; 69(9):559-63. PubMed ID: 7967317
[TBL] [Abstract][Full Text] [Related]
15. [Characteristics and treatment outcomes of INH-resistant or RFP-resistant tuberculosis].
Saito W; Nagayama N; Miyamoto M; Hara H; Suzuki J; Masuda K; Baba M; Tamura A; Nagai H; Akagawa S; Kawabe Y; Machida K; Kurashima A; Yotsumoto H
Kekkaku; 2003 Oct; 78(10):611-7. PubMed ID: 14621568
[TBL] [Abstract][Full Text] [Related]
16. [The immunological and cytogenetic changes in patients with pulmonary tuberculosis].
Chernushenko EF; Naĭda IV; Ryzhkova NA; Panasiukova OR; Didyk TV
Lik Sprava; 1994; (9-12):105-9. PubMed ID: 7541593
[TBL] [Abstract][Full Text] [Related]
17. [Use of systemic immunomodulator xymedone in distructive pulmonary tuberculosis].
Slabnov IuD; Vizel' AA; Cherepnev GV; Firsov OV; Sabirova LA
Probl Tuberk; 2000; (3):28-32. PubMed ID: 10900981
[TBL] [Abstract][Full Text] [Related]
18. [Immune system and pathogenesis of tuberculosis].
Knoring BE
Probl Tuberk; 1995; (1):18-21. PubMed ID: 7761372
[TBL] [Abstract][Full Text] [Related]
19. [Immune reactivity of patients with pulmonary tuberculosis suffering from chronic alcoholism].
Mel'nik VP
Vrach Delo; 1989 Apr; (4):82-5. PubMed ID: 2787943
[TBL] [Abstract][Full Text] [Related]
20. [Prevention of side effects of specific chemotherapy in patients with pulmonary tuberculosis].
Batian AN; Abramovskaia AK; Batian ON
Probl Tuberk; 1991; (7):60-2. PubMed ID: 1754594
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
